A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.4 EUR -2.44% Market Closed
Market Cap: 6.3m EUR
Have any thoughts about
Acticor Biotech SA?
Write Note

Acticor Biotech SA
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Acticor Biotech SA
Operating Expenses Peer Comparison

Comparables:
VLA
NANO
G
GNFT
ALERS
OSE

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
A
Acticor Biotech SA
PAR:ALACT
Operating Expenses
-€17.6m
CAGR 3-Years
-32%
CAGR 5-Years
-27%
CAGR 10-Years
-2%
Valneva SE
PAR:VLA
Operating Expenses
-€222m
CAGR 3-Years
-11%
CAGR 5-Years
-29%
CAGR 10-Years
-17%
Nanobiotix SA
PAR:NANO
Operating Expenses
-€61.3m
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
-22%
G
Genfit SA
PAR:GNFT
Operating Expenses
-€58m
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
-12%
Eurobio Scientific SA
PAR:ALERS
Operating Expenses
-€53.8m
CAGR 3-Years
-19%
CAGR 5-Years
-21%
CAGR 10-Years
-10%
OSE Immunotherapeutics SA
PAR:OSE
Operating Expenses
-€29.5m
CAGR 3-Years
7%
CAGR 5-Years
-7%
CAGR 10-Years
N/A

See Also

What is Acticor Biotech SA's Operating Expenses?
Operating Expenses
-17.6m EUR

Based on the financial report for Dec 31, 2023, Acticor Biotech SA's Operating Expenses amounts to -17.6m EUR.

What is Acticor Biotech SA's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-2%

Over the last year, the Operating Expenses growth was -16%. The average annual Operating Expenses growth rates for Acticor Biotech SA have been -32% over the past three years , -27% over the past five years , and -2% over the past ten years .

Back to Top